Ribon Therapeutics

Ribon Therapeutics

Biotechnology, 35 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States, 11-50 Employees

ribontx.com

  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is RIBON THERAPEUTICS

Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to ...

Read More

map
  • 35 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States Headquarters: 35 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States
  • 2015 Date Founded: 2015
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from RIBON THERAPEUTICS

Ribon Therapeutics Org Chart and Mapping

Employees

Barbara Yang

Clinical Medical Director

Elizabeth Mateer

Principal Scientist, Translational Sciences

Natalie Warholic

Associate Director, Clinical Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Ribon Therapeutics

Answer: Ribon Therapeutics's headquarters are located at 35 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States

Answer: Ribon Therapeutics's phone number is 61********

Answer: Ribon Therapeutics's official website is https://ribontx.com

Answer: Ribon Therapeutics's revenue is $25 Million to $50 Million

Answer: Ribon Therapeutics's SIC: 2834

Answer: Ribon Therapeutics's NAICS: 561110

Answer: Ribon Therapeutics has 11-50 employees

Answer: Ribon Therapeutics is in Biotechnology

Answer: Ribon Therapeutics contact info: Phone number: 61******** Website: https://ribontx.com

Answer: Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access